A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years
Under a Creative Commons license
open access
Keywords
13-Valent pneumococcal conjugate vaccine
Europe
Immunogenicity
Safety
Cited by (0)
Copyright © 2011 Elsevier Ltd.